Suspect multidrug-resistant gram-negative urinary tract infection in patients with a history of any of the following in the prior three months: |
|
|
|
|
NOTE: The predictive value of these risk factors for multidrug-resistant gram-negative urinary tract infections has not been systematically evaluated. In particular, the time interval since these exposures is not well validated. The threshold for empirically covering a multidrug-resistant infection varies with the severity of infection, with a lower threshold warranted for more severe disease. |
* This includes a single antibiotic dose given for prophylaxis prior to prostate procedures.
¶ The prevalence of multidrug resistance is not well documented in all parts of the world. Some countries where the prevalence is particularly high include India, Israel, Spain, and Mexico.